Indian biopharma leader Syngene International will invest $50 million in its first U.S. manufacturing facility, set to open in Baltimore City. The project is expected to generate 300 new jobs, strengthening the local economy. Maryland Governor Wes Moore praised the move, highlighting the state’s strong biopharma ecosystem and its potential to drive innovation. The facility will enhance Syngene’s U.S. market presence while fostering growth in Baltimore’s life sciences sector. New India Abroad reports that this investment underscores growing global ties in biopharma and positions Maryland as a key hub for cutting-edge research, manufacturing, and economic development in the industry.
Uploaded 8 months ago
Direct links
Image link
Image URL
Full image (linked)
Website (HTML)
Forums (BBCode)
Share image
Image information:
Indian biopharma leader Syngene International will invest $50 million in its first U.S. manufacturing facility, set to open in Baltimore City. The project is expected to generate 300 new jobs, strengthening the local economy. Maryland Governor Wes Moore praised the move, highlighting the state’s strong biopharma ecosystem and its potential to drive innovation. The facility will enhance Syngene’s U.S. market presence while fostering growth in Baltimore’s life sciences sector. New India Abroad reports that this investment underscores growing global ties in biopharma and positions Maryland as a key hub for cutting-edge research, manufacturing, and economic development in the industry.